Loading company…
Riskpilot
← Back to search
Sign in
Get full access
medTrans Suomi Oy
OY
Active
Y-tunnus 3326916-1
Kuninkaantammenkierto 10-B
Business and other management consultancy activities · NACE 7020
Est. 2022
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 0
EBITDA margin
—
0% vs 2023
Equity ratio
99.0%
Financial strength
Net profit 2024
EUR -548
0% vs 2023
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 0
—
EBITDA
EUR -548
+0%
Net profit
EUR -548
+0%
Total assets
EUR 45K
-8%
Equity
EUR 45K
-9%
Employees
—
—
Company information
Legal name
medTrans Suomi Oy
Y-tunnus number
3326916-1
Legal form
Osakeyhtiö
NACE code
7020 · Business and other management consultancy activities
Founded
22. marraskuuta 2022
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Muu liikkeenjohdon konsultointi (70220)
Contact
Address
Kuninkaantammenkierto 10-B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2023
0M
2023
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2023
0M
2023
0M
2024
Income statement
EUR thousands
Item
2023
2023
2024
Revenue
0
0
0
Staff expenses
−0
−0
−0
EBITDA
−1
−1
−1
Depreciation & amort.
−0
−0
−0
EBIT
−1
−1
−1
Net financials
0
0
0
Profit before tax
−1
−1
−1
Tax
−0
−0
−0
Net profit
−1
−1
−1
Balance sheet
EUR thousands
Item
2023
2023
2024
Total assets
49
49
45
Equity
49
49
45
Long-term debt
0
0
0
Short-term debt
0
0
0
Total debt
0
0
0
Financial ratios
5-year trend
EBITDA margin
-54800.0%
This company
15.8%
Market median
-346935% vs market
2023
2024
Equity ratio
99.0%
This company
38.2%
Market median
+159% vs market
2023
2024
Return on equity
-1.2%
This company
18.4%
Market median
-107% vs market
2023
2024
Net profit margin
-54800.0%
This company
8.1%
Market median
-676643% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-11-22 – 2023-06-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
UA
Urmas Arak
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
RH
Roni Heikki Juhani Penttilä
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Lilla Seglare Holding Ab
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Lilla Seglare Holding Ab
medTrans Suomi Oy
(this company)
Board network connections
Board members of medTrans Suomi Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Urmas Arak
Deputy Chief Executive Officer
0 companies
Roni Heikki Juhani Penttilä
Chief Executive Officer
0 companies